Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Griffioen

Gerard Griffioen, Linden BE

Patent application numberDescriptionPublished
20090054410THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES - This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an α-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides various methods for producing such substituted 1,2,4-thiadiazole derivatives.02-26-2009
20090186354METHODS AND TOOLS FOR THE SCREENING OF FACTORS AFFECTING PROTEIN MISFOLDING - The present invention relates in general to the fields of chemical, pharmaceutical and genetic screening and to diseases associated with protein misfolding. In particular, it discloses engineered cells and a system based thereon that can be used to screen for substances that affect protein misfolding. The engineered cells of the invention comprise one or more reporter genes under transcriptional control of a promoter that is responsive to protein misfolding.07-23-2009
20100144709THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES - The invention provides novel 1,2,4-thiadiazole derivatives useful for preventing or treating an α-synucleopathy such as Parkinson's disease, as well as pharmaceutical compositions including them as biologically active ingredients, and methods for manufacturing them.06-10-2010
20100197703N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES - This invention provides thiazolylpiperazine derivatives, and N-sulfonyl heterocyclic derivatives including phenyl- and benzyl-thiazolylpiperidine derivatives, and pharmaceutically acceptable salts thereof, which are useful active ingredients for administration in a method for the treatment of an α-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides methods for making such derivatives, and pharmaceutical compositions including such derivatives together with pharmaceutically acceptable excipients.08-05-2010
20100261707THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES - This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an α-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides various methods for producing such substituted 1,2,4-thiadiazole derivatives.10-14-2010

Gerard Johan Griffioen, Leuven - Heverlee BE

Patent application numberDescriptionPublished
20110287439CLASTOGENICITY TESTING - The present invention relates to improved methods for detecting agents that cause or potentiate DNA damage and to genetically transformed cells that may be usefully employed in such methods.11-24-2011

Kelly M. Griffioen, Kalamazoo, MI US

Patent application numberDescriptionPublished
20080310774Pouch with a valve - A pouch with a valve includes first and second pouch sidewalls sealed to one another to define an opening. A resealable closure mechanism is attached to inner surfaces of the first and second sidewalls proximate the opening to define a pouch interior opposite the opening. A channel extends from the interior to the opening between a section of the first closure element and the first sidewall. A pleated thermoplastic member is sealingly disposed in the channel and has an aperture disposed through the member. A fluid path may provide direct fluid communication between the interior and an exterior of the pouch, wherein the fluid path passes through an edge of the pouch defined by at least one of the first or second pouch sidewalls. A valve is sealingly disposed in the fluid path, wherein the valve comprises a pleated thermoplastic member attached to at least one of the first or second pouch sidewalls and having an aperture disposed through the pleated thermoplastic member to provide fluid communication between the interior and the exterior of the pouch.12-18-2008
20080310776Flow channels for a pouch - A pouch includes first and second opposing pouch walls and a plurality of flow channel protuberances that defines a flow channel between the first and second pouch walls and is disposed on an inner surface of at least one of the first or second pouch walls. At least one of the plurality of protuberances includes a first component extending from the at least one of the first or second pouch walls and a second component extending at a non-zero angle from the first component. The flow channel extends between an opening of the pouch and a portion of an interior of the pouch that is spaced from the opening.12-18-2008
20110085748Flow Channels for a Pouch - A pouch includes first and second opposing pouch walls and a plurality of flow channel protuberances that defines a flow channel between the first and second pouch walls and is disposed on an inner surface of at least one of the first or second pouch walls. At least one of the plurality of protuberances includes a first component extending from the at least one of the first or second pouch walls and a second component extending at a non-zero angle from the first component. The flow channel extends between an opening of the pouch and a portion of an interior of the pouch that is spaced from the opening.04-14-2011